Review
Open access
Sep 2026
Immune Checkpoint Inhibitor Combinations in Advanced Ovarian Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
The combination of ICIs with bevacizumab showed a consistent benefit in slowing cancer progression, with moderate certainty of evidence, and the choice of combination partner influences the robustness of this benefit.
Boram Choi, Youn Jin Choi, Keun Ho Lee
· Cancers · 0 citations